4’,6-Dihydroxy-4-methoxyisoaurone Inhibits the HIF-1α Pathway Through Inhibition of Akt/mTOR/p70S6K/4E-BP1 Phosphorylation
-
- Mi Chunliu
- Molecular Cancer Research Center, Yanbian University, China Chemical Biology Research Center, Department of Chemistry, Yanbian University, China
-
- Ma Juan
- Molecular Cancer Research Center, Yanbian University, China Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, College of Pharmacy, Yanbian University, China
-
- Shi Hui
- Molecular Cancer Research Center, Yanbian University, China Chemical Biology Research Center, Department of Chemistry, Yanbian University, China
-
- Li Jing
- Molecular Cancer Research Center, Yanbian University, China Chemical Biology Research Center, Department of Chemistry, Yanbian University, China
-
- Wang Fei
- Molecular Cancer Research Center, Yanbian University, China Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, College of Pharmacy, Yanbian University, China
-
- Lee Jung Joon
- Molecular Cancer Research Center, Yanbian University, China
-
- Jin Xuejun
- Molecular Cancer Research Center, Yanbian University, China Key Laboratory of Natural Resources of Changbai Mountain & Functional Molecules, Ministry of Education, College of Pharmacy, Yanbian University, China
書誌事項
- タイトル別名
-
- 4′,6-Dihydroxy-4-methoxyisoaurone Inhibits the HIF-1<i>α</i> Pathway Through Inhibition of Akt/mTOR/p70S6K/4E-BP1 Phosphorylation
- 4′,6-Dihydroxy-4-methoxyisoaurone Inhibits the HIF-1α Pathway Through Inhibition of Akt/mTOR/p70S6K/4E-BP1 Phosphorylation
この論文をさがす
抄録
4′,6-Dihydroxy-4-methoxyisoaurone (ISOA) is an isoaurone compound isolated from Trichosanthes kirilowii seeds, which was identified as an inhibitor of tumor growth. However, the mechanism by which ISOA inhibits hypoxia-inducible factor-1 (HIF-1)-mediated tumor growth is not fully understood. We here demonstrated the effect of ISOA on HIF-1 activation. ISOA showed a potent inhibitory activity against HIF-1 activation induced by hypoxia in various human cancer cell lines. This compound markedly decreased the hypoxia-induced accumulation of HIF-1α protein dose-dependently, whereas it did not affect the expressions of HIF-1β and topoisomerase-I (Topo-I). Further analysis revealed that the suppression of HIF-1α accumulation by ISOA was closely correlated with strong dephosphorylation of Akt, mammalian target of rapamycin (mTOR), and its effectors ribosomal protein S6 kinase (p70S6K) and eukaryotic initiation factor 4E-binding protein-1 (4E-BP1), a pathway known to regulate HIF-1α expression at the translational level. Furthermore, ISOA prevented hypoxia-induced expression of HIF-1 target genes and suppresses the invasiveness of tumor cells. Taken together, our results suggested that ISOA is an effective inhibitor of HIF-1 through targeting Akt/mTOR/p70S6K/4E-BP1 pathway, thereby, providing new perspectives into the mechanism of its anticancer activity.
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 125 (2), 193-201, 2014
公益社団法人 日本薬理学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205179835776
-
- NII論文ID
- 130004438624
-
- NII書誌ID
- AA11806667
-
- COI
- 1:CAS:528:DC%2BC2cXhtFaltb7M
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 025531348
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可